New Articles
  July 20th, 2015 | Written by

Implant Sciences Ships $1.2 Million in Trace Detection Systems

[shareaholic app="share_buttons" id="13106399"]


  • Explosives trace detection is used in mass transit, cargo screening, infrastructure protection, and aviation security.
  • Implant CEO: Our ramped up manufacturing capacity enables us to execute more orders.
  • November 2014: TSA ordered 1,170 EDTs from Implant.

Implant Sciences Corporation announced that it recently shipped $1.2 million of its explosives trace detectors to customers around the world. The sales were comprised of its QS-B220 desktop explosives and drugs trace detector and its QS-H150 handheld explosives trace detector. These systems were sold across four continents to be deployed in a variety of applications including mass transportation, cargo screening, infrastructure protection, and aviation security.

Implant is a manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications. Its QS-B220 uses Ion Mobility Spectrometry (IMS) to detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 also utilizes IMS technology and has been proven to perform well in a variety of temperatures and challenging environments, from jungles to deserts.

“We continue to win additional orders, fueled by our wins from the TSA and international airports across the EU,” said Bill McGann, Implant Sciences’ CEO. “Our ability to successfully build and ship these additional units to other customers is due to our ramped up manufacturing capacity, which enables us to execute on more orders than ever before.”

In November 2014, the U.S. Transportation Security Administration (TSA) ordered 1,170 QS-B220 Desktop Explosive Trace Detectors from Implant. The TSA deployed the equipment at multiple airports across the U.S.

“As we have executed upon the flurry of ETD sales opportunities in the European Union, we have not relented in our market penetration in other parts of the world,” added Darryl Jones, Implant Sciences’ Vice President of Global Sales and Marketing. “The demand for our technology continues to grow globally for numerous applications, and as an ETD market leader in both technology and sales, we are gratified and fully prepared to support this demand.”

Implant Sciences’ ETDs have received approvals and certifications from several international regulatory agencies in the U.S., European Union, China, Russia, France, and Germany. Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security.